EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Outcomes of International Trials Can Be Affected by Poorquality Translations
Editorial Archive

Outcomes of International Trials Can Be Affected by Poorquality Translations

Quality in translation is important. Everybody knows that. In this piece, Simon Andriesen, founder and CEO of MediLingua, will show you how to stay away from US court...
Continue Reading →
Why the Intranasal Influenza Vaccine is Not Recommended this Season
Editorial Archive

Why the Intranasal Influenza Vaccine is Not Recommended this Season

Each year, as autumn is well underway, seasonal influenza vaccinations become a topic of conversation for everyone in general and for those with children in particula...
Continue Reading →
Sponsors and CROs: Closing the Technological Gap in Clinical Trials
Editorial Archive

Sponsors and CROs: Closing the Technological Gap in Clinical Trials

Engagement has recently been established as a key concept within clinical trials. This trend has delivered a multitude of benefits for participants, who, rather than ...
Continue Reading →
Serving on an FDA Advisory Committee: One Member’s Point of View
Editorial Archive

Serving on an FDA Advisory Committee: One Member’s Point of View

The Federal Food, Drug, and Cosmetic Act (FD&C Act) is a federal law enacted by Congress. Along with other federal laws, it establishes the legal framework within...
Continue Reading →
Risk-based Quality Management: Improving Trials Data through Minimalism
Editorial Archive

Risk-based Quality Management: Improving Trials Data through Minimalism

There is no doubt about the importance of maintaining quality standards throughout clinical research processes, but in recent years the regulatory bodies have begun t...
Continue Reading →
New Approaches to Measuring Health Outcomes – Leveraging a Gaming Platform
Editorial Archive

New Approaches to Measuring Health Outcomes – Leveraging a Gaming Platform

Clinical trials employ a variety of approaches to measure the health status of patients and changes in their health due to treatment. In many therapy areas, subjectiv...
Continue Reading →
How Emerging Companies Can Make Being Small a Strategic Advantage
Editorial Archive

How Emerging Companies Can Make Being Small a Strategic Advantage

Small- to mid-sized (aka “emerging”) firms bring fewer resources to bear on the same drug development problems as large pharmaceutical companies. All developers face ...
Continue Reading →
Going All In on eCOA
Editorial Archive

Going All In on eCOA

Significant growth opportunities in the ePRO field mean the industry is calling out for solutions, advice and guidance that can help deliver on its promises. JCS talk...
Continue Reading →
eSource: Optimising the Sponsor, Site, and CRO Experience
Editorial Archive

eSource: Optimising the Sponsor, Site, and CRO Experience

The clinical research industry has long hungered for a nextlevel innovation to make paper all but obsolete in clinical research. In eSource, that innovation has final...
Continue Reading →
Drug Development in Systemic Lupus Erythematosus – Can it be Successful?
Editorial Archive

Drug Development in Systemic Lupus Erythematosus – Can it be Successful?

Systemic lupus erythematosus (SLE) is an autoimmune disease that causes the immune system to produce several types of antibodies, particularly against cell nuclei. Th...
Continue Reading →
Catalyst: 12th January 2026
Quotient